The Problem
Most Vision Loss is Preventable
An estimated 80 million people in the US general population have vision loss due to disease (diabetes, macular degeneration, etc.).
There is only 1 Eye Specialist for every 17,000 Americans.
It’s estimated that, only 40% of patients have their annual eye exam.
Spect's Strategy
Today
Screening for eye disease
Our network of ophthalmologists are screening for Diabetic Retinopathy, Age-Related Macular Degeneration, and more through images captured with our Ophthalmic Camera.
Tomorrow
Expand Access to Eyecare
We’re evolving our platform to automate and streamline the capture of retinal images to improve patient access and care.
Beyond
Global Data Analytics
We envision a platform to enable the screening of Parkinson’s, Stroke, Heart Disease, and Kidney Disease.
Our Solution
The Spect Platform
Today, we invented a vertically integrated platform from the ground up that solves all the pain points that are routine with conventional retinal exams.
This exam is reimbursable through CPT billing, satisfies quality metrics (HEDIS/MIPs), and can be used for value based care.
Current Solutions:
Built for Specialists
Current solutions are inflexible, costly, and difficult to use.
Quality Results
Image gradability around 50-60%
Intensive Setup Costs
Hours of training, difficult to integrate in clinical workflow, immobile
Large Upfront Capital Expense
Starting price from $5,000+
Our Solution:
Built for all Healthcare Staff
Our solution is a frictionless workflow and enables all healthcare staff to obtain quick results.
Quick Quality Results
Exams in 3 minutes or less and Image gradability above 95%
No Initial Setup Costs
Untrained medical assistants can learn to use the platform in under 15 minutes
No Capital Expense
Cost financed through a low monthly fee or other payment structure that meets your needs
Screenable diseases with Spect’s network of licensed specialists
Retinal image data is then sent to Spect’s network of licensed eye specialists (e.g. ophthalmologists and optometrists) for evaluation.
Common Eye Diseases
- Stages of Diabetic Retinopathy with and without macular edema
- Stages of Dry Macular Degeneration
- End Stage Wet Macular Degeneration
- Myopic Degeneration
- Epiretinal Membrane
- Retinal Vein Occlusion
Rarer Eye Diseases
- Choroidal Nevus
- Macular Hole
- Optic Nerve suspicious for Glaucoma
- Optic Disc Edema
- And Many More
Markets Spect Serves
The Spect solution is proudly deployed nationwide. We are heavily focused on screening the Senior Population.
.png)